Press "Enter" to skip to content

Biocartis partners with AstraZeneca on lung cancer diagnostics

Following the agreement, a prospective lung cancer study with Biocartis’s Idylla EGFR Mutation Test will be conducted in Belgium, France, Germany and Italy.

Original source: https://health.economictimes.indiatimes.com/news/pharma/biocartis-partners-with-astrazeneca-on-lung-cancer-diagnostics/66863966?utm_source=RSS&utm_medium=ETRSS

Also Read:   Physical un-fitness linked with depression, anxiety in middle-aged women